Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Risk adjusted net present value: What is the current valuation of Takeda Pharmaceutical's TAK-227?
TAK-227 is a small molecule commercialized by Takeda Pharmaceutical, with a leading Phase II program in Celiac Disease. According to...